Estrella Immunopharma Ownership | Who Owns Estrella Immunopharma?
Estrella Immunopharma Ownership Summary
Estrella Immunopharma is owned by 11.15% institutional investors, 60.42% insiders, and 28.43% retail investors. Wells fargo & company/mn is the largest institutional shareholder, holding 0% of ESLA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.62% of its assets in Estrella Immunopharma shares.
ESLA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Estrella Immunopharma | 11.15% | 60.42% | 28.43% |
| Sector | Healthcare Stocks | 245.07% | 12.10% | -157.17% |
| Industry | Biotech Stocks | 380.48% | 11.73% | -292.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Wells fargo & company/mn | - | - | - |
| Royal bank of canada | - | - | - |
| Morgan stanley | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Wells fargo & company/mn | - | - | - |
| Royal bank of canada | - | - | - |
| Morgan stanley | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | - | - | -1.00 |
| Royal bank of canada | - | - | -6.60K |
| Wells fargo & company/mn | - | - | -264.39K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wells fargo & company/mn | - | - | -264.39K |
| Royal bank of canada | - | - | -6.60K |
| Morgan stanley | - | - | -1.00 |
Sold Out
| Holder | Change |
|---|---|
| Morgan stanley | -1.00 |
| Royal bank of canada | -6.60K |
| Wells fargo & company/mn | -264.39K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 15 | -6.25% | 4,794,274 | -7.43% | 11 | 7.38% | 6 | -45.45% | 5 | 150.00% |
| Mar 31, 2026 | 16 | 6.67% | 5,178,824 | 418.09% | 12 | 177.41% | 11 | -21.43% | 2 | 100.00% |
| Dec 31, 2025 | 15 | 15.38% | 999,605 | 34.50% | 2 | 65.59% | 14 | 250.00% | 1 | -83.33% |
| Sep 30, 2025 | 13 | 18.18% | 743,186 | 17.07% | 2 | 65.02% | 4 | -33.33% | 6 | 200.00% |
| Jun 30, 2025 | 11 | - | 634,819 | 3.53% | 1 | 61.15% | 6 | 20.00% | 2 | -33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 268.61K | 0.62% | 600.00 |
| Vanguard Morn Total Stk Mkt Idx Investor | 268.61K | 0.62% | 600.00 |
| Vanguard MStar Total Stk Mkt Idx Invest | 268.61K | 0.62% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 148.25K | 0.34% | - |
| Fidelity Extended Market Index | 81.03K | 0.19% | -18.22K |
| iShares Micro-Cap ETF | 49.01K | 0.11% | -654.00 |
| Fidelity Series Total Market Index | 26.16K | 0.06% | -1.39K |
| Northern Trust Extended Eq Market Idx | 19.24K | 0.04% | - |
| NT Ext Equity Mkt Index Fund - Lending | 19.24K | 0.04% | - |
| Fidelity Total Market Index | 16.76K | 0.04% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 07, 2025 | Xu Jiandong | Chief Financial Officer | Buy | $1.33K |
| Sep 11, 2025 | Xu Jiandong | Chief Financial Officer | Buy | $104.00 |
| Sep 22, 2025 | Xu Jiandong | Chief Financial Officer | Buy | $1.16K |
| Mar 04, 2022 | Li Jianwei | Co-Chief Executive Officer | Buy | $44.68B |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2025 Q4 | 1 | - |
| 2025 Q3 | 2 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
ESLA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools